(redirected from acetylcholinesterase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to acetylcholinesterase inhibitor: anticholinesterase
See: deterrent
References in periodicals archive ?
Larvicides and acetylcholinesterase inhibitors from Kalanchoe species.
The effects of huperzine A, an acetylcholinesterase inhibitor, on the enhancement of memory in mice, rats and monkeys.
The effectiveness and safety of the coadministration of memantine HCl extended release and acetylcholinesterase inhibitors (AChEIs), together with donepezil HCl, was based on the results of a randomized and double-blind, placebo-controlled study of 677 outpatients on a stable dose of AChEIs.
The potency of this compound led us to apply the same assay on a well established acetylcholinesterase inhibitor, physostigmine (Fig.
Chemical and pharmacological characterization of galanthamine, and acetylcholinesterase inhibitor, and its derivates.
Acetylcholinesterase inhibitors were considered good candidate drugs for Parkinson's-associated dementia because results from prior studies had shown clear cholinergic, deficits in patients with this disease, and their pathology seemed to match what occurs in patients with Alzheimer's disease.
In all of the studies we've conducted evaluating EVP-6124 to-date, we have seen pro-cognitive dose-dependent effects and we believe the novel mechanism has the potential to alleviate the undesirable side effects caused by other systemic compounds - for example, acetylcholinesterase inhibitors - which are dose-limited by side effects.
The study was conducted in patients suffering from moderate Alzheimer's disease, with Lu AE58054 administered as an add-on to donepezil, a commonly used acetylcholinesterase inhibitor.
Donepezil increases brain levels of acetylcholinesterase inhibitor and has been proven efficacious in Alzheimer's.
Aricept has historically been the preferred acetylcholinesterase inhibitor (AChEI), as evidenced by its status as the patient and market-share leader, and the availability of the lower-cost generic donepezil will result in donepezil--branded and generic formulations combined--retaining its status as the patient-share leader.
Rivastigmine a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status.
The double-blind, randomized trial is the first to examine the effect of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine and the acetylcholinesterase inhibitor donepezil against donepezil monotherapy, said Dr.

Full browser ?